Trials / Unknown
UnknownNCT04836611
Cannabinoides Concentrations and Hyperemesis Syndrom Occurrence in Regular Cannabis Consumer (CANEMESE)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Cannabinoide Hyperemesis Syndrom (CHS) is defined as a recurrent syndrome of intractable vomiting that occurs in chronic cannabis consumers. The diagnosis is linked to clinical criteria only. The physiopathology of CHS is unknown and we observe an increase of cases with this syndrom since 2016 (Schreck et al., 2018). The aim of this study is to investigate the involvement of exogenous cannabinoids concentrations in chronic cannabis users in the occurrence of CHS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 1 blood sample | 2 groups of subjects (group 1 : with diagnosis of CHS - group 2 : no diagnosis of CHS) will have 2 blood and 1 urine samples + 1 questionnaire |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2021-04-08
- Last updated
- 2021-10-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04836611. Inclusion in this directory is not an endorsement.